|
OMIM |
Link |
Information gain |
01 |
|
amobarbital, deficient n-hydroxylation of
|
[NCBI]
|
0.00189937
|
|
|
drug metabolism, poor, cyp2d6-related
|
[NCBI]
|
0.000743553
|
|
|
drug metabolism, poor, cyp2c19-related
|
[NCBI]
|
0.00036916
|
|
|
ehlers-danlos syndrome, type vi
|
[NCBI]
|
0.000310316
|
|
|
HIF1A
|
[NCBI]
|
0.000214249
|
|
|
phenformin 4-hydroxylation
|
[NCBI]
|
0.000154334
|
|
|
25-@hydroxyvitamin d3 deficiency, selective
|
[NCBI]
|
0.000126569
|
|
|
VHL
|
[NCBI]
|
0.000119826
|
|
|
carbimazole sensitivity
|
[NCBI]
|
0.000109296
|
|
|
hypotension, orthostatic
|
[NCBI]
|
0.000104243
|
|
|
CYP2D6
|
[NCBI]
|
0.000102224
|
|
|
CMAH
|
[NCBI]
|
9.68716e-05
|
|
|
corticosterone methyloxidase type ii deficiency
|
[NCBI]
|
8.5472e-05
|
|
|
adrenal hyperplasia, congenital, due to steroid 11-beta-hydroxylase deficiency
|
[NCBI]
|
8.38094e-05
|
|
|
cerebrotendinous xanthomatosis
|
[NCBI]
|
8.22757e-05
|
|
|
hypoascorbemia
|
[NCBI]
|
8.22757e-05
|
|
|
EGLN3
|
[NCBI]
|
8.19863e-05
|
|
|
EGLN2
|
[NCBI]
|
8.19863e-05
|
|
|
dopamine beta-hydroxylase deficiency, congenital
|
[NCBI]
|
7.82805e-05
|
|
|
EGLN1
|
[NCBI]
|
7.06326e-05
|
|
|
CYP3A5
|
[NCBI]
|
5.9213e-05
|
|
|
osteogenesis imperfecta, type iia
|
[NCBI]
|
5.77874e-05
|
|
|
TH
|
[NCBI]
|
5.73393e-05
|
|
|
CYP2C19
|
[NCBI]
|
5.40966e-05
|
|
|
PLOD1
|
[NCBI]
|
5.29662e-05
|
|
|
osteogenesis imperfecta, type i
|
[NCBI]
|
4.91208e-05
|
|
|
EPHX1
|
[NCBI]
|
4.71361e-05
|
|
|
CYP2A6
|
[NCBI]
|
4.71361e-05
|
|
|
danubian endemic familial nephropathy
|
[NCBI]
|
4.57083e-05
|
|
|
NR1I2
|
[NCBI]
|
4.11857e-05
|
|
|
SLOS
|
[NCBI]
|
3.37537e-05
|
|
|
JMJD2C
|
[NCBI]
|
3.32658e-05
|
|
|
CYP2R1
|
[NCBI]
|
3.17648e-05
|
|
|
CYP1A1
|
[NCBI]
|
3.14204e-05
|
|
|
ASPH
|
[NCBI]
|
3.05692e-05
|
|
|
amplified in osteosarcoma 9
|
[NCBI]
|
2.95754e-05
|
|
|
CYP4A11
|
[NCBI]
|
2.87249e-05
|
|
|
VDR
|
[NCBI]
|
2.74889e-05
|
|
|
COMT
|
[NCBI]
|
2.70025e-05
|
|
|
CD1A
|
[NCBI]
|
2.61886e-05
|
|
|
phenylketonuria
|
[NCBI]
|
2.55648e-05
|
|
|
TPH2
|
[NCBI]
|
2.52388e-05
|
|
|
EPAS1
|
[NCBI]
|
2.44212e-05
|
|
|
TPH1
|
[NCBI]
|
2.40515e-05
|
|
|
CYP1A2
|
[NCBI]
|
2.40515e-05
|
|
|
CYP11A1
|
[NCBI]
|
2.37037e-05
|
|
|
DBH
|
[NCBI]
|
2.22198e-05
|
|
|
CYP1B1
|
[NCBI]
|
2.19634e-05
|
|
|
H3F3A
|
[NCBI]
|
2.19634e-05
|
|
|
FMO3
|
[NCBI]
|
1.95368e-05
|
|
|
STAT5B
|
[NCBI]
|
1.93739e-05
|
|
|
CYP3A4
|
[NCBI]
|
1.90611e-05
|
|
|
isoniazid inactivation
|
[NCBI]
|
1.72484e-05
|
|
|
cortisol 11-beta-ketoreductase deficiency
|
[NCBI]
|
1.61423e-05
|
|
|
H6PD
|
[NCBI]
|
1.52956e-05
|
|
|
ABCC2
|
[NCBI]
|
1.37294e-05
|
|
|
ABCB11
|
[NCBI]
|
1.34971e-05
|
|
|
COL1A1
|
[NCBI]
|
1.25589e-05
|
|
|
TTR
|
[NCBI]
|
1.25317e-05
|
|
|
PAM
|
[NCBI]
|
1.25112e-05
|
|
|
AHR
|
[NCBI]
|
1.0733e-05
|
|
|
SHBG
|
[NCBI]
|
1.05519e-05
|
|
|
FAAH
|
[NCBI]
|
9.32926e-06
|
|
|
RA
|
[NCBI]
|
9.30897e-06
|
|
|
MPO
|
[NCBI]
|
8.64004e-06
|
|
|
TNF
|
[NCBI]
|
8.35565e-06
|
|
|
SLE
|
[NCBI]
|
8.35431e-06
|
|
|
VEGF
|
[NCBI]
|
8.28092e-06
|
|
|
CDK2
|
[NCBI]
|
7.9251e-06
|
|
|
G6PD
|
[NCBI]
|
7.71833e-06
|
|
|
PNMT
|
[NCBI]
|
7.66183e-06
|
|
|
CJD
|
[NCBI]
|
7.36829e-06
|
|
|
PTH
|
[NCBI]
|
5.88211e-06
|
|
|
CAT
|
[NCBI]
|
4.19324e-06
|
|
|
SLC6A3
|
[NCBI]
|
2.97604e-06
|
|
|
NGFB
|
[NCBI]
|
2.45382e-06
|
|
|
PPARA
|
[NCBI]
|
2.09221e-06
|
|
|
NPY
|
[NCBI]
|
9.94764e-07
|
|
|
EGF
|
[NCBI]
|
6.79462e-07
|
|
|
EPO
|
[NCBI]
|
1.26233e-07
|
|
|
AR
|
[NCBI]
|
1.45783e-09
|
|